Article info

Download PDFPDF

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
Free
  1. Correspondence to:
    Dr P Geborek
    Department of Rheumatology, Lund University Hospital, SE 221 85 Lund, Sweden; Pierre.geborekreum.lu.se
View Full Text

Citation

Geborek P, Bladström A, Turesson C, et al
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

Publication history

  • Accepted January 3, 2005
  • First published February 4, 2005.
Online issue publication 
April 15, 2005

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.